Logo
Annual
Results
for the year ended
30 June
2022
RE-IMAGINING
THE HEALTHCARE
SYSTEM

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

EXCEL DOWNLOAD
   Year ended 30  June 
2022 
R'000 
Year ended 30  June 
2021 
R'000 
Balance at beginning of the period  3 255 724  3 119 095 
Issue of share capital*  17 
Share premium*  10 180  4 395 
Vested share-based awards*  (10 197) (4 402)
Share-based awards reserve  13 860  10 787 
Distributions to shareholders  (195 137) (194 788)
Net profit for the period  315 341  310 655 
Profit attributable to minorities  167 900  165 251 
Changes in ownership  (13 023) (20 000)
Disposal of subsidiary  —  (2 353)
Distributions to non-controlling interests  (98 780) (132 923)
Balance at end of the period  3 445 885  3 255 724 
*   During the current financial year, 1 760 006 shares vested as follows:
  90 000 shares were exercised at the weighted average price of R3.55 and the grant date price was R6.20;
  440 002 shares were exercised at the weighted average price of R5.26 and the grant date price was R6.20;
  526 667 shares were exercised at the weighted average price of R5.26 and the grant date price was R5.50;
  210 001 shares were exercised at the weighted average price of R5.40 and the grant date price was R6.20; and
  493 336 shares were exercised at the weighted average price of R5.40 and the grant date price was R5.50.
  At the end of the financial year, 19 850 000 shares were outstanding for the incentive share scheme.
  The fair value of the shares granted was determined by obtaining the share price as traded on the JSE.